ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO536

Lambda Light Chain Predominance Links C1q Deposition to Endocapillary Hypercellularity in IgA Nephropathy

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: From Inflammation to Fibrosis


  • Baier, Eva, Universitatsmedizin Gottingen Klinik fur Nephrologie und Rheumatologie, Gottingen, Niedersachsen, Germany
  • Tampe, Bjoern, Universitatsmedizin Gottingen Klinik fur Nephrologie und Rheumatologie, Gottingen, Niedersachsen, Germany

Involvement of the complement system is a key driver of immune complex-mediated nephritogenicity in immunoglobulin A nephropathy (IgAN), being the most prevalent primary glomerulopathy worldwide. Despite growing insights on the pathophysiological relevance of lambda (λ) light chain (LC) predominance in IgAN, implications of glomerular complement deposition remain largely elusive. Therefore, we here aimed to systematically assess the correlative pattern of clinicopathological findings and glomerular complement C1q and C3c deposits in λ-LC predominant biopsy-proven IgAN.


A total of 37 patients with biopsy-proven IgAN obtained between 2016 and 2021 were retrospectively included in a single center observational study. Clinical data assessment comprised age, sex, serum creatinine levels, blood urea nitrogen, eGFR, complement C3/ C4 and proteinuria. Oxford-scored lesions mesangial (M) and endocapillary hypercellularity (E), segmental sclerosis (S), tubular atrophy (T), crescentic formations (C), and other lesions scored analogous to the Banff classification were evaluated. Immune histochemistry-detected glomerular deposits of complement factors C1q/ C3c and kappa (κ)/ λ LCs were semiquantitatively scored. Two groups were formed according to the λ-LC status: λ-LC positive (n=20) and λ-LC negative (n=17). Clinicopathological correlations were analyzed in both groups regarding glomerular C1q and C3c deposits by means of multivariable linear regression.


Enrolled patients featured a median creatinine level of 1.5 mg/dL. C1q and C3c deposition featured no significant association with serum parameters indicative of kidney injury or proteinuria. We identified endocapillary hypercellularity to feature the strongest association with glomerular C1q deposition in the λ-LC positive group (ρ=0.7; β=0.745, p<0.001). In the λ-LC negative group, a significant correlation of C3c deposition and mesangial hypercellularity was identified (ρ=0.6; β=0.762, p<0.001).


We here show a correlative pattern of λ LC-associated deposition of complement factors C1q and C3c in distinct histopathological features of IgAN implying an involvement of the classical pathway in the preset of λ-LC predominance.